Area riservata



Trattamento di varici con laser trans-dermico

Ivacaftor Improves Lung Function And Symptoms In Cystic Fibrosis Patients With Specific Genetic Mutation
Scritto da Cystic Fibrosis News From Medical News Today   
VascolareIvacaftor, a novel oral agent that potentiates a membrane channel blocked in patients aged six years and older with cystic fibrosis caused by the G551D mutation, significantly improves lung function and reduces pulmonary exacerbations, according to phase 3 data reported at the European Respiratory Society's Annual Congress 2012, Vienna, on Monday (3 September 2012)...
Fonte: Cystic Fibrosis News From Medical News Today
 

Aggiungi commento


Codice di sicurezza
Aggiorna